FI103202B1 - Menetelmä terapeuttisesti käyttökelpoisten 4-sulfonamido-1,4-dihydrokinoliiinijohdannaisten valmistamiseksi - Google Patents
Menetelmä terapeuttisesti käyttökelpoisten 4-sulfonamido-1,4-dihydrokinoliiinijohdannaisten valmistamiseksiInfo
- Publication number
- FI103202B1 FI103202B1 FI933762A FI933762A FI103202B1 FI 103202 B1 FI103202 B1 FI 103202B1 FI 933762 A FI933762 A FI 933762A FI 933762 A FI933762 A FI 933762A FI 103202 B1 FI103202 B1 FI 103202B1
- Authority
- FI
- Finland
- Prior art keywords
- sulfonamido
- preparation
- therapeutically useful
- dihydroquinoline derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66178091A | 1991-02-27 | 1991-02-27 | |
| US66178091 | 1991-02-27 | ||
| US70000491A | 1991-05-14 | 1991-05-14 | |
| US70000491 | 1991-05-14 | ||
| PCT/US1992/001093 WO1992015565A1 (en) | 1991-02-27 | 1992-02-11 | Nmda antagonists |
| US9201093 | 1992-02-11 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI933762A FI933762A (fi) | 1993-08-26 |
| FI933762A0 FI933762A0 (fi) | 1993-08-26 |
| FI103202B1 true FI103202B1 (fi) | 1999-05-14 |
| FI103202B FI103202B (fi) | 1999-05-14 |
Family
ID=27098383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI933762A FI103202B (fi) | 1991-02-27 | 1993-08-26 | Menetelmä terapeuttisesti käyttökelpoisten 4-sulfonamido-1,4-dihydroki noliiinijohdannaisten valmistamiseksi |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0573562B1 (ko) |
| JP (1) | JP3465794B2 (ko) |
| KR (1) | KR100224045B1 (ko) |
| AT (1) | ATE137225T1 (ko) |
| AU (1) | AU660969B2 (ko) |
| CA (1) | CA2104297C (ko) |
| DE (1) | DE69210229T2 (ko) |
| DK (1) | DK0573562T3 (ko) |
| ES (1) | ES2089511T3 (ko) |
| FI (1) | FI103202B (ko) |
| GR (1) | GR3019772T3 (ko) |
| HU (1) | HU217425B (ko) |
| NO (1) | NO180485C (ko) |
| WO (1) | WO1992015565A1 (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5318985A (en) * | 1991-12-20 | 1994-06-07 | Merrell Dow Pharmaceuticals Inc. | Potentiation of NMDA antagonists |
| ATE404201T1 (de) * | 1992-06-22 | 2008-08-15 | Univ California | Glycinrezeptorantagonisten und ihre verwendung |
| US5475007A (en) * | 1993-05-28 | 1995-12-12 | The Regents Of The University Of California | 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and the use thereof |
| DE69416324T2 (de) * | 1993-11-29 | 1999-06-10 | Merrell Pharmaceuticals Inc., Cincinnati, Ohio | Heterocyclische benzolsulfonyliminderivate als inhibitoren der il-1 wirkung |
| ES2131297T3 (es) * | 1993-11-29 | 1999-07-16 | Merrell Pharma Inc | Nuevos derivados de bencenosulfonilamina como inhibidores de la accion il-1. |
| CA2788656A1 (en) | 2010-02-16 | 2011-08-25 | Pfizer Inc. | (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8719102D0 (en) * | 1987-08-12 | 1987-09-16 | Merck Sharp & Dohme | Therapeutic agents |
| IL93610A0 (en) * | 1989-03-08 | 1990-12-23 | Merck Sharp & Dohme | Tetrahydroquinoline derivatives,their preparation and pharmaceutical compositions containing them |
| ZA903588B (en) * | 1989-05-16 | 1991-02-27 | Merrell Dow Pharma | Excitatory amino acid antagonists |
-
1992
- 1992-02-11 WO PCT/US1992/001093 patent/WO1992015565A1/en active IP Right Grant
- 1992-02-11 ES ES92907466T patent/ES2089511T3/es not_active Expired - Lifetime
- 1992-02-11 KR KR1019930702559A patent/KR100224045B1/ko not_active IP Right Cessation
- 1992-02-11 HU HU9302433A patent/HU217425B/hu not_active IP Right Cessation
- 1992-02-11 AT AT92907466T patent/ATE137225T1/de not_active IP Right Cessation
- 1992-02-11 AU AU15320/92A patent/AU660969B2/en not_active Ceased
- 1992-02-11 DK DK92907466.4T patent/DK0573562T3/da active
- 1992-02-11 JP JP50728592A patent/JP3465794B2/ja not_active Expired - Lifetime
- 1992-02-11 CA CA002104297A patent/CA2104297C/en not_active Expired - Lifetime
- 1992-02-11 DE DE69210229T patent/DE69210229T2/de not_active Expired - Lifetime
- 1992-02-11 EP EP92907466A patent/EP0573562B1/en not_active Expired - Lifetime
-
1993
- 1993-08-26 NO NO933042A patent/NO180485C/no not_active IP Right Cessation
- 1993-08-26 FI FI933762A patent/FI103202B/fi active
-
1996
- 1996-04-25 GR GR960401099T patent/GR3019772T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1992015565A1 (en) | 1992-09-17 |
| AU660969B2 (en) | 1995-07-13 |
| DE69210229D1 (de) | 1996-05-30 |
| JP3465794B2 (ja) | 2003-11-10 |
| DE69210229T2 (de) | 1996-11-14 |
| ATE137225T1 (de) | 1996-05-15 |
| HU9302433D0 (en) | 1993-11-29 |
| NO933042D0 (no) | 1993-08-26 |
| NO180485C (no) | 1997-04-30 |
| CA2104297A1 (en) | 1992-08-28 |
| HUT67301A (en) | 1995-03-28 |
| GR3019772T3 (en) | 1996-07-31 |
| DK0573562T3 (da) | 1996-05-13 |
| NO180485B (no) | 1997-01-20 |
| FI933762A (fi) | 1993-08-26 |
| AU1532092A (en) | 1992-10-06 |
| EP0573562A1 (en) | 1993-12-15 |
| FI933762A0 (fi) | 1993-08-26 |
| JPH06505746A (ja) | 1994-06-30 |
| HU217425B (hu) | 2000-01-28 |
| KR100224045B1 (ko) | 1999-10-15 |
| EP0573562B1 (en) | 1996-04-24 |
| FI103202B (fi) | 1999-05-14 |
| ES2089511T3 (es) | 1996-10-01 |
| CA2104297C (en) | 2003-05-27 |
| KR930703257A (ko) | 1993-11-29 |
| NO933042L (no) | 1993-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI102676B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 3-amido- ja 3-sulfamidoindolyylijohdannaisten valmistamiseksi | |
| FI890282A0 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi | |
| FI98455B (fi) | Menetelmä terapeuttisesti aktiivisten indolijohdannaisten valmistamiseksi | |
| FI98454B (fi) | Menetelmä terapeuttisesti aktiivisten 3-indolyylitioasetaattijohdannaisten valmistamiseksi | |
| FI103202B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten 4-sulfonamido-1,4-dihydrokinoliiinijohdannaisten valmistamiseksi | |
| DE69230224D1 (de) | Potenzierung von nmda-antagonisten | |
| FI97388B (fi) | Menetelmä heterosyklisten NMDA-antagonistien valmistamiseksi | |
| NO178375C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive NMDA-antagonister | |
| NO178782C (no) | Fremgangsmåte for fremstilling av et farmasöytisk akseptabelt gelpreparat | |
| NO904678L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzylpyrrolidenderivater. | |
| FI954169A0 (fi) | Menetelmä 3-substituoitujen 2-oksoindolijohdannaisten valmistamiseksi | |
| NO175363C (no) | Fremgangsmåte for fremstilling av klormetaner |